During the last session, Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s traded shares were 2.26 million, with the beta value of the company hitting 1.14. At the end of the trading day, the stock’s price was $1.98, reflecting an intraday gain of 20.73% or $0.34. The 52-week high for the MIST share is $2.75, that puts it down -38.89 from that peak though still a striking 43.43% gain since the share price plummeted to a 52-week low of $1.12. The company’s market capitalization is $105.59M, and the average trade volume was 742.39K shares over the past three months.
Milestone Pharmaceuticals Inc (MIST) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.40. MIST has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Milestone Pharmaceuticals Inc (MIST) registered a 20.73% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 20.73% in intraday trading to $1.98, hitting a weekly high. The stock’s 5-day price performance is 13.14%, and it has moved by 1.02% in 30 days. Based on these gigs, the overall price performance for the year is 22.98%.
The consensus price target of analysts on Wall Street is $10, which implies an increase of 80.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $10 and $10 respectively. As a result, MIST is trading at a discount of -405.05% off the target high and -405.05% off the low.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
In the rating firms’ projections, revenue will decrease -100.00% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -7.22%. While earnings are projected to return 54.82% in 2025, the next five years will return 26.29% per annum.
MIST Dividends
Milestone Pharmaceuticals Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 3.26 million shares, is of RTW INVESTMENTS, LP’s that is approximately 4.9211% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $4.3 million.
Also, the Mutual Funds coming in first place with the largest holdings of Milestone Pharmaceuticals Inc (MIST) shares are Fidelity NASDAQ Composite Index Fund and SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF . Data provided on Dec 31, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 19.87 shares. This amounts to just over 0.04 percent of the company’s overall shares, with a $39346.0 market value. The same data shows that the other fund manager holds slightly less at 19.12, or about 0.04% of the stock, which is worth about $37851.0.
